Lipocine
LPCN
LPCN
30 hedge funds and large institutions have $8.88M invested in Lipocine in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
93% less call options, than puts
Call options by funds: $5K | Put options by funds: $76K
Holders
30
Holding in Top 10
–
Calls
$5K
Puts
$76K
Top Buyers
| 1 | +$436K | |
| 2 | +$318K | |
| 3 | +$183K | |
| 4 |
Millennium Management
New York
|
+$67K |
| 5 |
QCMA
Quad Capital Management Advisors
New York
|
+$56.3K |
Top Sellers
| 1 | -$112K | |
| 2 | -$43K | |
| 3 | -$34K | |
| 4 |
SIM
Spark Investment Management
New York
|
-$34K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$26.8K |